Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Differential diagnosis with adrenergic beta blockers].

G Bodem

    Fortschritte Der Medizin
    |August 16, 1979
    PubMed
    Summary

    Beta-adrenergic blocking agents vary in potency, selectivity, and side effects. Understanding these differences is crucial for effective patient treatment and managing potential adverse reactions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Theophylline pharmacokinetics in the aged: result of a dose finding study in 12 geriatric patients.

    Methods and findings in experimental and clinical pharmacology·1987
    Same author

    [Current questions on digitalis therapy].

    Der Internist·1983
    Same author

    [Clinically relevant drug interactions with cardiac glycosides].

    Fortschritte der Medizin·1982
    Same author

    Disease-related alterations in cardiac glycoside disposition.

    Clinical pharmacokinetics·1982
    Same author

    Kinetics and cardiac effects of propranolol in humans.

    Klinische Wochenschrift·1982
    Same author

    [Drug interactions between digitoxin and quinidine?].

    Deutsche medizinische Wochenschrift (1946)·1982

    Area of Science:

    • Pharmacology
    • Cardiology

    Background:

    • Multiple beta-adrenergic blocking agents are available.
    • These agents exhibit diverse characteristics including beta-blocking potency, selectivity, intrinsic activity, and membrane stabilizing properties.
    • Pharmacokinetic profiles also vary significantly among these drugs.

    Purpose of the Study:

    • To compare the properties of various beta-adrenergic blocking agents.
    • To highlight the clinical significance of beta-blocker selectivity in managing patients with obstructive lung disease and peripheral vascular conditions.
    • To discuss the implications of intrinsic activity on side effects and therapeutic outcomes.

    Main Methods:

    • Comparative analysis of available beta-adrenergic blocking agents.
    • Review of pharmacological properties: potency, selectivity, intrinsic activity, membrane stabilization.
    • Evaluation of pharmacokinetic variability and clinical implications.

    Main Results:

    • Beta-blocker selectivity is critical for avoiding adverse effects in patients with obstructive lung disease and peripheral vascular issues.
    • Intrinsic activity can contribute to side effects like nightmares and headaches, but may also lead to less pronounced heart rate reduction.
    • Discrepancies in bioavailability can potentially be managed by adjusting oral dosage.

    Conclusions:

    • The choice of beta-adrenergic blocking agent should consider its specific pharmacological profile and selectivity.
    • Clinical application requires careful assessment of potential side effects related to intrinsic activity and membrane stabilization.
    • Pharmacokinetic variations necessitate appropriate dose adjustments for optimal therapeutic efficacy.

    Related Experiment Videos